Understanding Follicular Lymphoma
![Understanding Follicular Lymphoma image](https://healthtree.org/images-resize?width=1000&height=1000&imageUrl=https%253A%252F%252Ffirebasestorage.googleapis.com%252Fv0%252Fb%252Fhealthtree-production.appspot.com%252Fo%252Fgallery%25252Fpublic%25252FImmunotherapy%252520basics_cc49e32e-7438-4d69-8697-d028799fe4cd.jpg%253Falt%253Dmedia)
Event Description
Are you new to follicular lymphoma or getting lost in all of the complex medical information? If you are a patient or a caregiver experiencing any stage of follicular lymphoma, we invite you to join us to learn from a top panel of experts who will teach you the essential things you need to know to manage this diagnosis best. This Roundtable will cover an in-depth explanation of what follicular lymphoma is, causes and risk factors, symptoms, diagnosis, staging, testing, lines of treatment, maintenance, palliative care, and clinical trials. At the end of the event, there will be extensive time for you to have your questions answered directly by the experts. Whether you are newly diagnosed or simply need help clearing up the confusion, this is an event you won't want to miss!
Schedule & Agenda
![The panelist Kat Richardson](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FKat_205dcbf3-d19c-4c3b-88b0-8f8b1d620abe.jpeg?alt=media)
Kat will introduce the agenda of the event and featured speakers.
![The panelist Kat Richardson](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FKat_205dcbf3-d19c-4c3b-88b0-8f8b1d620abe.jpeg?alt=media)
Kat will introduce the agenda of the event and featured speakers.
![The panelist Dr. Samuel Yamshon](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%203.55.50%E2%80%AFPM_3badb570-dcb4-4ed2-8a7d-9e89587225d4.png?alt=media)
Dr. Yamshon will give a basic description of follicular lymphoma, some of the potential causes and risk factors for the disease, and symptoms associated with follicular lymphoma.
![The panelist Dr. Samuel Yamshon](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%203.55.50%E2%80%AFPM_3badb570-dcb4-4ed2-8a7d-9e89587225d4.png?alt=media)
Dr. Yamshon will give a basic description of follicular lymphoma, some of the potential causes and risk factors for the disease, and symptoms associated with follicular lymphoma.
![The panelist Dr. Talal Hilal](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%204.01.23%E2%80%AFPM_1fdd2d26-7413-4913-8caf-513392b2bcfb.png?alt=media)
Dr. Hilal will discuss testing for follicular lymphoma, how the disease is diagnosed, and what staging and grading mean.
![The panelist Dr. Talal Hilal](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%204.01.23%E2%80%AFPM_1fdd2d26-7413-4913-8caf-513392b2bcfb.png?alt=media)
Dr. Hilal will discuss testing for follicular lymphoma, how the disease is diagnosed, and what staging and grading mean.
![The panelist Dr. Sarah Rutherford](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%203.26.12%E2%80%AFPM_202c65ab-49d8-4ded-965b-a9e9de994506.png?alt=media)
Dr. Rutherford will discuss lines of treatment, including watch and wait, as well as maintenance. She will also discuss other options such as palliative care and clinical trials.
![The panelist Dr. Sarah Rutherford](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%203.26.12%E2%80%AFPM_202c65ab-49d8-4ded-965b-a9e9de994506.png?alt=media)
Dr. Rutherford will discuss lines of treatment, including watch and wait, as well as maintenance. She will also discuss other options such as palliative care and clinical trials.
Type your questions in the chat, and the expert panel will answer them!
Type your questions in the chat, and the expert panel will answer them!
Speakers & Moderators
![The panelist Dr. Sarah Rutherford](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%203.26.12%E2%80%AFPM_202c65ab-49d8-4ded-965b-a9e9de994506.png?alt=media)
Dr. Sarah Rutherford is an Assistant Professor of Medicine in the Division of Hematology/Oncology at Weill Cornell Medicine. She is a graduate of the University of Virginia School of Medicine. She completed Internship and Residency in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia and Fellowship in Hematology/Oncology at New York-Presbyterian Hospital/Weill Cornell Medical College. Dr. Rutherford has clinical expertise in lymphoma. Her research focuses on improving outcomes in patients with aggressive lymphomas. She has a particular interest in helping patients to have an accurate understanding of their diagnosis. She has received honors from Weill Cornell Medical College and the American Society of Hematology, and support from the New York State Empire Clinical Research Investigator Program for her research in diffuse large B-cell lymphoma. She has experience in caring for patients with a variety of lymphomas and hematologic disorders including Hodgkin lymphoma, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and marginal zone lymphoma.
![The panelist Dr. Samuel Yamshon](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%203.55.50%E2%80%AFPM_3badb570-dcb4-4ed2-8a7d-9e89587225d4.png?alt=media)
Samuel Yamshon, M.D. is an Assistant Professor of Medicine at Weill Cornell Medicine/New York Presbyterian Hospital. Dr. Yamshon cares for patients with blood cancers with a specific focus on lymphoma and improving outcomes for patients using innovative treatments like cellular immunotherapies including CAR T-cell therapy. Dr. Yamshon received his B.A. from Columbia University and completed his medical training at the University of California, Davis. He returned to New York to train in Internal Medicine at Weill Cornell Medicine, where he also completed his fellowship in Hematology and Oncology. At Weill Cornell Medicine, he specializes in treating patients with lymphoma using cellular therapies including bone marrow transplantation and CAR T cell therapy, and is involved in clinical research dedicated to improving outcomes for patients with lymphoma. He has been involved in lymphoma research for over a decade, co-authoring numerous publications and several presentations at national meetings. Dr. Yamshon is also an Editorial Fellow for the journal Leukemia & Lymphoma. He has received multiple research grants including the American Society of Clinical Oncology (ASCO) Young Investigator Award and the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program.
![The panelist Dr. Talal Hilal](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-04%20at%204.01.23%E2%80%AFPM_1fdd2d26-7413-4913-8caf-513392b2bcfb.png?alt=media)
Talal Hilal, M.D., is a hematologist/oncologist and bone marrow transplant physician with a clinical focus on chronic lymphocytic leukemia, lymphoid malignancies, and rare histiocytic neoplasms. Dr. Hilal attended medical school at the Royal College of Surgeons in Ireland. He obtained training in internal medicine at the University of Kentucky and in hematology/oncology at the Mayo Clinic in Phoenix, Arizona where he served as Chief Fellow. Dr. Hilal's clinical practice focuses on the treatment of chronic lymphocytic leukemia, various types of lymphoma, and histiocytic neoplasms. He is interested in incorporating various modalities of therapy that help serve individual patient needs, including using novel targeted therapies, bispecific T-cell engagers, and cellular therapy. He is part of the bone marrow transplant and chimeric antigen receptor (CAR) T-cell therapy programs where he prescribes specialized treatments for patients with lymphoid malignancies.
![The panelist Kat Richardson](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FKat_205dcbf3-d19c-4c3b-88b0-8f8b1d620abe.jpeg?alt=media)
Kat is from Lehi, Utah and is the Health Education Manager for lymphoma. She has worked in healthcare for a decade now, and earned her degree in Community Health Education and Promotion. Kat is passionate about disease prevention as well as improving quality of life and health equity. She enjoys reading, hiking, baking, ice skating, gardening, time with her family and friends, and most of all, spoiling her nieces and nephew.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Follicular lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
Thanks to our HealthTree Community for Follicular Lymphoma Sponsors:
![Regeneron](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRegeneron_logo_(2).svg_64899492-87cd-4df9-9d4b-07f9618df890.png?alt=media)
![Bristol Myers Squibb](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FBristol%20Myers%20Squibb_f22fa9b6-b205-4828-bea5-d645566d3243.png?alt=media)